How to identify and manage non-response to clozapine?

Mujeeb Shad, Emma Felzien, Kamalika Roy, Simrat Sethi

    Research output: Contribution to journalArticle

    Abstract

    Clozapine is the only approved treatment for Treatment-Refractory Schizophrenia. Here we describe a case series of three hospitalized patients with clozapine nonresponse. One of them responded to clozapine after dose adjustments were made for an interaction between clozapine and ciprofloxacin. The other two cases remained clozapine nonresponders despite optimizing clozapine treatment. However, both these patients responded to other antipsychotic medications (APMs) with better tolerability than observed with clozapine treatment. This case series focuses on diagnosing a genuine from a pseudo-nonresponse to clozapine and to consider other APMs in genuine nonresponse before switching to invasive interventions, such as ECT.

    Original languageEnglish (US)
    Pages (from-to)50-52
    Number of pages3
    JournalAsian Journal of Psychiatry
    Volume45
    DOIs
    StatePublished - Oct 1 2019

    Fingerprint

    Clozapine
    Antipsychotic Agents
    Social Adjustment
    Therapeutics
    Ciprofloxacin
    Schizophrenia

    Keywords

    • Clozapine
    • Identify
    • Manage
    • Non-response

    ASJC Scopus subject areas

    • Psychology(all)
    • Psychiatry and Mental health

    Cite this

    How to identify and manage non-response to clozapine? / Shad, Mujeeb; Felzien, Emma; Roy, Kamalika; Sethi, Simrat.

    In: Asian Journal of Psychiatry, Vol. 45, 01.10.2019, p. 50-52.

    Research output: Contribution to journalArticle

    Shad, Mujeeb ; Felzien, Emma ; Roy, Kamalika ; Sethi, Simrat. / How to identify and manage non-response to clozapine?. In: Asian Journal of Psychiatry. 2019 ; Vol. 45. pp. 50-52.
    @article{4154107a6a844bc0a08ecfc0bf9a2ea3,
    title = "How to identify and manage non-response to clozapine?",
    abstract = "Clozapine is the only approved treatment for Treatment-Refractory Schizophrenia. Here we describe a case series of three hospitalized patients with clozapine nonresponse. One of them responded to clozapine after dose adjustments were made for an interaction between clozapine and ciprofloxacin. The other two cases remained clozapine nonresponders despite optimizing clozapine treatment. However, both these patients responded to other antipsychotic medications (APMs) with better tolerability than observed with clozapine treatment. This case series focuses on diagnosing a genuine from a pseudo-nonresponse to clozapine and to consider other APMs in genuine nonresponse before switching to invasive interventions, such as ECT.",
    keywords = "Clozapine, Identify, Manage, Non-response",
    author = "Mujeeb Shad and Emma Felzien and Kamalika Roy and Simrat Sethi",
    year = "2019",
    month = "10",
    day = "1",
    doi = "10.1016/j.ajp.2019.08.016",
    language = "English (US)",
    volume = "45",
    pages = "50--52",
    journal = "Asian Journal of Psychiatry",
    issn = "1876-2018",
    publisher = "Elsevier",

    }

    TY - JOUR

    T1 - How to identify and manage non-response to clozapine?

    AU - Shad, Mujeeb

    AU - Felzien, Emma

    AU - Roy, Kamalika

    AU - Sethi, Simrat

    PY - 2019/10/1

    Y1 - 2019/10/1

    N2 - Clozapine is the only approved treatment for Treatment-Refractory Schizophrenia. Here we describe a case series of three hospitalized patients with clozapine nonresponse. One of them responded to clozapine after dose adjustments were made for an interaction between clozapine and ciprofloxacin. The other two cases remained clozapine nonresponders despite optimizing clozapine treatment. However, both these patients responded to other antipsychotic medications (APMs) with better tolerability than observed with clozapine treatment. This case series focuses on diagnosing a genuine from a pseudo-nonresponse to clozapine and to consider other APMs in genuine nonresponse before switching to invasive interventions, such as ECT.

    AB - Clozapine is the only approved treatment for Treatment-Refractory Schizophrenia. Here we describe a case series of three hospitalized patients with clozapine nonresponse. One of them responded to clozapine after dose adjustments were made for an interaction between clozapine and ciprofloxacin. The other two cases remained clozapine nonresponders despite optimizing clozapine treatment. However, both these patients responded to other antipsychotic medications (APMs) with better tolerability than observed with clozapine treatment. This case series focuses on diagnosing a genuine from a pseudo-nonresponse to clozapine and to consider other APMs in genuine nonresponse before switching to invasive interventions, such as ECT.

    KW - Clozapine

    KW - Identify

    KW - Manage

    KW - Non-response

    UR - http://www.scopus.com/inward/record.url?scp=85071654175&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=85071654175&partnerID=8YFLogxK

    U2 - 10.1016/j.ajp.2019.08.016

    DO - 10.1016/j.ajp.2019.08.016

    M3 - Article

    VL - 45

    SP - 50

    EP - 52

    JO - Asian Journal of Psychiatry

    JF - Asian Journal of Psychiatry

    SN - 1876-2018

    ER -